Objective: Surgical pain scales (SPS) consist of 4 items that measure pain at rest, during normal activities, and during work/exercise and quantify unpleasantness of worst pain, which are valid and responsive in men undergoing hernia repair. Our objective was to evaluate the psychometric properties of SPS in women undergoing vaginal surgery for pelvic organ prolapse and stress urinary incontinence.
tification of pain are essential to optimize postoperative pain management. The surgical pain scales (SPS) consist of 4 visual analog scales that measure pain at rest, pain during normal activities, and pain during work or exercise, as well as pain unpleasantness. 2 The SPS are used to compare pain levels between groups at a single point in time or to track changes in pain levels for individual patients over time or after operations. The SPS were originally constructed to assess patient-level outcomes in men enrolled in a multicenter randomized clinical trial of open versus laparoscopic inguinal herniorrhaphy. 2 Longitudinal data from 2164 men enrolled in this trial confirmed the reliability, validity, and responsiveness of the SPS. 2 Several studies have demonstrated clinically important differences in pain response and experience between men and women. 3Y5 Therefore, one cannot assume that the psychometric properties demonstrated in men in the original validation of the SPS will be similar in women.
The visual analog scale (VAS) is widely used to evaluate both acute and chronic pain. 6 However, the VAS has inherent limitations including a high rate of ''unscorable'' data and low face validity among elderly patients. 7 As such, the VAS may be suboptimal for measuring pain in women undergoing pelvic reconstructive surgery, many of whom are elderly. We, therefore, modified the SPS so that the responses to the 4 scales used a numeric rating scale (NRS, 0Y10), which has properties that are not age dependent. 7 The aim of this study was to assess the psychometric properties of this modified SPS in women undergoing surgery for pelvic organ prolapse and stress urinary incontinence.
MATERIALS AND METHODS
This was a planned supplementary study of the Operations and Pelvic Muscle Training in the Management of Apical Support Loss (OPTIMAL) trial, a multicenter randomized trial conducted by the Pelvic Floor Disorders Network (PFDN). 8 The principal aims of the OPTIMAL trial are to (1) compare surgical outcomes after sacrospinous ligament fixation versus uterosacral ligament vaginal vault suspension and (2) assess the role of perioperative behavioral and pelvic floor muscle training versus usual care in women undergoing vaginal surgery for apical prolapse and stress urinary incontinence using a 2 Â 2 randomized factorial design. The PFDN is sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and consists of 7 clinical sites, a data coordinating center, and National Institute of Health staff. A detailed description of the OPTIMAL trial design is published. 8 The study sample for this analysis included a subset of 169 consecutive women enrolled in the OPTIMAL trial between February 2008 and August 2009. All OPTIMAL trial participants are adult women with stage II to stage IV pelvic organ prolapse and coexisting stress urinary incontinence symptoms who have prolapse at the vaginal apex (with or without a uterus) and opted for vaginal surgery for prolapse repair. All PFDN sites obtained local institutional review board approval, and all participants completed informed consent. Enrolled participants were randomized to receive either a sacrospinous ligament fixation or uterosacral vaginal vault suspension as part of their vaginal prolapse repair. In addition, all participants received a tension-free vaginal tape (TVT) to treat their stress urinary incontinence. The participants also underwent a second randomization to either a perioperative behavioral and pelvic muscle training program or usual clinical care. Randomization was stratified by site with separate randomization schedules generated by the data coordinating center using permuted blocks. The participants and evaluators remained blinded to treatment assignment. The perioperative behavioral therapy program began 2 to 4 weeks before surgery and continued for 3 months after surgery. Follow-up of the OPTIMAL trial is ongoing so for purposes of this analysis, comparisons within and between the surgical and behavioral interventions were not performed and blinding of the participants, investigators, and data coordinating center was maintained.
The original 4 scales of the SPS were modified so that each of the 4 items is scored on an 11-point NRS (0Y10) rather than a VAS (Fig. 1) . Additionally, we removed ''having sex'' from the item ''How much pain did you have when you were having sex, exercising, doing strenuous work or lifting objects you used to be able to lift comfortably?'' because we did not think this activity was consistent with the other activities listed in the item when applied to women. Otherwise, the stems of each of the 4 items of the SPS are unchanged from the original scale.
Demographics, medical history, and standardized pelvic examination were completed at enrollment. The participants completed several self-administered questionnaires including the modified SPS and the SF-36. 2, 3 Postoperatively, all participants received a standardized set of postoperative instructions including instructions on resumption of physical activities. Postoperative pain management was administered according to the standard at each clinical site. The participants self-administered the modified SPS and SF-36 again at 2 weeks and 6 months after surgery. At 2 weeks, the participants also rated their average pain during normal activities compared to before surgery on a 5-point scale (from ''much better'' to ''much worse'').
The validity of the SPS was assessed using the same general approach as used by McCarthy et al. 2 Because these scales are intended to be used in the perioperative period, it is important to establish validity of the scales both preoperatively and postoperatively. Construct validity considers the extent to which a scale or subscale produces scores consistent with those of another instrument with known characteristics. A series of correlational analyses examined two of the variants of construct validity, convergent and discriminant validity, of the 4 scales and the 8 dimensions of the SF-36. 3 Specifically, we tested the hypothesis that the SPS would have larger correlations with the SF-36 bodily pain scale (convergent validity) and smaller correlations with its other domains such as the mental health subscale (divergent validity). Construct validity was assessed at baseline and 6 months postoperatively. Correlations between the SPS and the SF-36 bodily pain scale were also evaluated at a visit 2 weeks after surgery, as this is the point of assessment when pain is expected to be the highest.
As with validity, the responsiveness of the SPS was assessed using the same general approach used in the original development of the instruments. 2 Although limited, evidence suggests that pelvic organ prolapse does not usually result in pain 9 ; therefore, we anticipated that the major factor affecting pain and activity level in the participants enrolled in OPTIMAL would be the surgery itself and not their prolapse or urinary incontinence. We hypothesized that participants would have low pain scores at baseline with higher pain scores 2 weeks after surgery. By 6 months, pain scores should approach or improve beyond baseline levels. To examine the responsiveness of the SPS, we evaluated change over 2 periods: baseline to 2 weeks and 2 weeks to 6 months. Within each period, the participants were classified into one of 3 pain groups (improved, unchanged, or worse) based on the change in the SF-36 bodily pain scale. The minimum clinically important difference (MCID) of the SF-36 scale is 2 points for the bodily pain scale below 40 and 3 points for the bodily pain scale above 40. 3 We considered the participants' pain to be ''unchanged'' if the change in the pain scale score was smaller than the MCID. Likewise, we considered the participants' pain to be ''improved'' if the bodily pain scale scores increased by more than the MCID and ''worse'' if they decreased by more than the MCID. The direction and amount of change of the SPS was determined for each group (improved, unchanged, and worse) at each of the 2 periods and compared using analysis of variance (ANOVA).
Additionally, 2 weeks after surgery, the participants rated their current pain during normal activities to their pain during normal activities before surgery on a 5-point scale from ''very much better'' to ''very much worse.'' The participants were then classified as improved, worse or unchanged. As described previously, the direction and amount of change of the SPS was determined for each group for each of the 2 periods and compared using ANOVA. We also evaluated the effect size for the SPS as a third measure of responsiveness. The effect size is the change in mean values between 2 time points divided by the standard deviation of the baseline value. An effect size of 0.2 to 0.5 is considered small, 0.5 to 0.7 is considered moderate, and 0.8 and greater is considered large. 10 For convergent and divergent validity, a sample size of 85 participants is sufficient to detect correlations of 0.3 or greater. In the assessment of responsiveness, 150 participants provides at least 80% power (>, 0.05; 2-sided test) to detect differences among the groups using one-way ANOVA defined by improvement, no change, and worsening in pain during normal activity of the same magnitude and variability of those seen by McCarthy et al, 2 with the additional assumption that the proportion of the participants in the 3 categories is roughly 1/2:1/4:1/4, respectively.
RESULTS
Ninety-two percent (155) of the 169 of participants completed both the modified SPS and the SF-36 at baseline and at 2 weeks postoperatively, and 149 participants (88%) completed both questionnaires at 6 months postoperatively. The study sample had a mean (SD) age of 58 (10) years. Most of the women were white (89%), whereas 6.5% were African American and 4.5% were Asian or other; 20% of the sample identified themselves as Hispanic. At enrollment, 54 (35%) of 154 of the study sample had stage II pelvic organ prolapse, 90 (58.5%) of the 154 women had stage III pelvic organ prolapse and 10 (6.5%) of the 154 women had stage IV pelvic organ prolapse. Table 1 displays mean and SD for the 4 SPS items at baseline, 2 weeks and 6 months after the operation, as well as change in scores from baseline to 2 weeks and from 2 weeks to 6 months. Pain at rest, pain during normal activity, and pain during work/exercise were significantly worse 2 weeks after surgery; whereas pain at rest, pain during normal activity, pain during work/exercise, and pain unpleasantness all significantly improved between 2 weeks and 6 months after surgery. Similarly, all 4 measures of pain improved significantly from baseline to 6 months postoperatively. Overall, the mean pain scores were relatively low (range, 0.9Y4.0) at baseline and at 2 weeks and 6 months after surgery, although the pain scores among individual patients varied over the full spectrum of the scales.
Construct validity for the SPS is demonstrated in Table 2 . Convergent validity is confirmed as each of the 4 items on the SPS correlates more strongly with the SF-36 bodily pain subscale (r = 0.57 to 0.71) than the other SF-36 subscales. Similarly, the modified SPS items correlated less strongly with the SF-36 subscales not expected to be as directly related to bodily pain, such as mental health (r = 0.28 to 0.42) and social functioning subscales (r = 0.37 to 0.52), demonstrating the divergent validity of the scales. Similar relationships are noted between the SPS and the SF-36 subscales at 2 weeks and 6 months postoperatively (data not shown). The mean values for the 3 pain intensity scales showed higher levels of pain as activity level increased at each time point (Table 1) .
The mean change in the SPS scores for participants whose pain was classified as improved, unchanged, or worse based on the SF-36 bodily pain scale from baseline to 2 weeks and from 2 weeks to 6 months are shown in Tables 3 and 4 , respectively. †Change from baseline to 2 weeks (2-week value minus baseline); positive numbers represent an increase in pain, negative numbers represent a decrease in pain.
‡Change from 2 weeks to 6 months (6-month value minus 2 weeks). CI, confidence interval; IQR, intraquartile range; SD, standard deviation. The SPS scores changed significantly in each of the 3 groups (improved, unchanged, and worse) during both periods (P G 0.0001 and P = 0.0004, respectively). Participants whose pain was worse based on the SF-36 bodily pain scale (99/155 [63%]) from baseline to 2 weeks experienced the largest change in the SPS, with a mean (SD) change of 1.9 (2.8) and a large effect size (0.99). Participants whose pain was unchanged had the smallest change in the SPS (mean [SD] change, j0.77 [2.6]; effect size, 0.36). From 2 weeks to 6 months, 75% (112) of 149 participants were classified as having improved pain by the SF-36 bodily pain scale. This group demonstrated the greatest change in the SPS scores over this period, with a mean (SD) improvement of 2.5 (2.4) and a large effect size (0.96). Those classified as unchanged or worse over this period (12.5% each) had substantially less improvement in SPS score.
Additionally, 2 weeks after surgery, the participants were asked to rate their average pain during normal activities compared to before their surgery (external anchor). Thirty-two percent (49) of the 154 participants classified their pain as ''a little worse'' or much worse, and this group had the largest change in the SPS score (mean [SD] change, +2.0 [3.4] ; effect size, 0.84). In contrast, 52% (n = 81) reported that their pain was ''a little better'' or ''much better'' and 16% (n = 24) reported ''no change,'' and the change in the SPS score was substantially less in these groups (mean [SD] 
DISCUSSION
Pain, often called the ''fifth vital sign,'' must be assessed and managed for all hospitalized patients and those undergoing office-based procedures. Pain management is an essential component of quality patient care. The Centers for Medicare and Medicaid Services (CMS) considers pain assessment before initiation of treatment and follow-up to be a measureable quality indicator (www.cms.gov). In the clinical setting, pain intensity is typically assessed using a zero-to-10 NRS. This simple measurement of pain is practical, easy for patients to understand, and easy for caregivers to interpret. However, pain expression is a complex process with both sensory and emotional components, and this common one-dimensional assessment of pain may not adequately capture the pain experience for postoperative patients. The SPS were constructed to assess both the sensory and affective components of postoperative pain while remaining simple and efficient. By assessing pain resulting from different levels of activity as well as assessing the ''unpleasantness'' of pain, the SPS have the advantage of being able to identify the circumstances and associated magnitudes under which pain occurs and assess qualitative features of the patient experience. 2 The simplicity of the modified SPS also makes it ideal for obtaining values at multiple time points, thereby establishing a temporal pattern.
The SPS, as originally constructed, consisted of four 150-mm VAS. Although the VAS have excellent psychometric properties and are commonly used to assess pain, they also have several disadvantages. 6, 11, 12 The VAS are difficult to administer to patients with perceptual-motor problems; impractical to administer over the phone and score in a clinical setting; and difficult for elderly and less educated patients to understand and use. 6, 7, 11, 12 The NRS and the VAS agree well and are equally sensitive in assessing acute pain after surgery. 11 However, the NRS is more practical, easier to understand for most people, does not require clear vision, dexterity, paper and pen to administer; and, unlike the VAS, its properties are not age-dependent. 7, 11 The NRS has higher face validity and lower rates of missing or unscorable data among older surgical patients compared to the VAS. 7 In one study of 504 patients undergoing surgery, the rate of unscorable data from the VAS was 14% to 18% compared with 4% for the NRS. 7 The mean (SD) age of women undergoing surgery for pelvic organ prolapse in the United States is 57 (14) years, with a large proportion of these women older than 65 years. 13 Therefore, we modified the SPS by converting its responses from *For baseline G40: T2 points for ''no change'' category, 92 for ''improving'', less than j2 for ''worsening''; for baseline Q40: T3 points for ''no change,'' 93 for ''improving'', less than j3 for ''worsening.'' †F statistics testing whether SPS change differs among the 3 categories according to SF-36 physical functioning subscale. VAS to NRS to improve its applicability in women undergoing pelvic reconstructive surgery. In this study, we demonstrated that these modified SPS are valid and responsive and can be used to evaluate various aspects of perioperative pain in women undergoing surgery for pelvic organ prolapse and stress urinary incontinence. Similar to the study by McCarthy et al, we found that the modified SPS demonstrated both concurrent and divergent validity. The correlations seen in this study between the SPS and the bodily pain scale of the SF-36 ranged from 0.51 to 0.74; these are comparable to if not better than those described in the original manuscript validating the SPS among male hernia patients (r = 0.44 to 0.60). As predicted, the sensory and affective pain ratings of the SPS were highly correlated with the SF-36 bodily pain scale at each time point, whereas correlations were substantially lower between scales not thought to be directly related to pain. Validity was further confirmed as the modified SPS scores increased with increasing levels of activity. We did not assess the internal consistency or test-retest reliability of the modified SPS in this study; however, these properties were excellent in the study by McCarthy et al, and the NRS generally have excellent internal consistency and good test-retest reliability. 2, 12 Importantly, the modified SPS was sensitive to change after surgery. The 3 SPS intensity scales demonstrated a significant increase in reported pain 2 weeks after surgery, and a significant decline in reported pain from 2 weeks to 6 months after surgery. The pain unpleasantness scale did not change from baseline to 2 weeks after surgery but did show a significant improvement from 2 weeks to 6 months after surgery. In the 2-week postoperative period, the SPS mirrored the responsiveness of the SF-36 bodily pain scale. Most participants reported worsening of pain during this period, and the mean SPS scores increased appropriately with an effect size indicating excellent responsiveness. Not surprisingly, participants whose pain was improved by the SF-36 reported less pain on the SPS with a moderate effect size, whereas those whose pain was unchanged showed the smallest change in the SPS. Three quarters of participants demonstrated an improvement in pain by the SF-36 between 2 weeks and 6 months after surgery, and this group showed the largest improvements in SPS scores with an effect size consistent with excellent responsiveness (0.96). In contrast, those who did not indicate improvement in pain by the SF-36 during this period had significantly less change in their SPS scores.
In addition to classifying patients' change in pain by the SF-36 bodily pain scale, we also asked patients at 2 weeks after surgery to rate their change in pain during normal activities compared to before surgery. Those who indicated that their pain during normal activities was worse compared to before surgery had a significant worsening of reported pain by the SPS. However, this only represented 32% of the participants, approximately half of the number of participants whose pain worsened during this period according to the SF-36 bodily pain scale. Of those who indicated that their pain was unchanged or improved by this self-rating of change in pain, there was almost no change in average SPS score. In fact, it seems that the global rating of change in the pain item used did not correlate well with the SPS or the SF-36 bodily pain scale. There are several factors that may have contributed to this lack of correlation. First, this item was only assessed at 2 weeks postoperatively, and it seems unlikely that many women would have resumed normal activities by this period, particularly given the standard postoperative instructions. In addition, external anchors asking for comparisons before a treatment event like the one used in this study are subject to recall bias. A patient's experience of change in pain over a 2-week period may not correlate with their current pain or pain within the last 24 hours, as assessed by the SPS. Other investigators have suggested that global ratings of change are potentially problematic because patients' assessment of their past health might be influenced by their current health status. 14, 15 We found similar issues using this type of global rating of change when evaluating the psychometric properties of a functional activity scale in this same study population. 16 The primary strength of this study is its prospective longitudinal design in a well-characterized sample of women with pelvic floor disorders from multiple centers in the United States. The women in our study reported relatively low levels of pain at each time point, potentially limiting our ability to demonstrate the full range of variability and responsiveness of the scales. Pelvic organ prolapse and stress urinary incontinence do not, in themselves, typically cause pain. 9 As such, this study principally evaluated the pain associated with pelvic reconstructive surgery and its recovery. All participants in this study underwent surgery using a vaginal approach. One of the primary advantages of vaginal surgery is its quicker recovery and lower postoperative pain relative to other approaches, particularly surgeries requiring laparotomy. There is a risk of a ''floor effect'' in this study, particularly at 6 months when patients are expected to have completely recovered from surgery. Additional research in different populations using different surgical approaches including those requiring laparotomy and laparoscopy and with larger samples would be valuable to further evaluate the psychometric properties of the SPS.
A number of pain scales and questionnaires exist for use in clinical practice and research. 6, 11 Few are specifically designed for assessing pain in the postoperative period. We demonstrated that a modified version of the SPS using the NRS to avoid limitations inherent to VAS is valid, responsive, and ideally suited to assess perioperative pain in women undergoing pelvic reconstructive surgery. The simplicity of the modified SPS makes it well suited for clinical outcome research as well as to quantify patients' pain in clinical care to improve patients'satisfaction and quality of care.
